No fees unless we win.
Get a free consultation
As reported by the Wall Street Journal and Fierce Pharma, a former Novartis Pharmaceuticals executive, Min Amy Guo, is suing the drug company, reporting that she was fired after suggesting that the way Novartis proposed awarding a contract to McKesson for a study of cancer drug Afinitor, “presented a conflict of interest and an appearance of kickbacks under the disguise of research.”
Min Amy Guo had been executive director of the Health Economics and Outcomes Research Group. She indicates that two years ago she objected to a proposed study that would look at uses of the Affinitor breast cancer treatment that were not approved by the FDA. This is referred to as “off-label use.” She said the project was proposed in 2012 and was going to take a month to complete, but was “too costly.” Therefore, instead of the study going through Guo’s research group, it was going to be overseen by the Oncology Scientific Operations-Managed Markets group, which the lawsuit said is “focused on client interaction,” not on research.
This is not the first time such allegations have been made against the drug company. Only four years ago, Novartis paid $422.5 million in fines and civil penalties to settle allegations that it offered kickbacks to doctors to increase prescriptions of its blood pressure drugs Diovan, Exforge and Tekturna.
The law firm of Zoll & Kranz, LLC (“ZK”) devotes its practice to the field of pharmaceutical and medical device litigation. ZK is dedicated to compelling companies to produce safer products. Injured clients and partnering attorneys from across the U.S. appreciate and rely upon over 50 years of combined experience in pharmaceutical mass torts and multidistrict litigation. ZK’s experienced team includes a practicing physician-attorney and all the technology, knowledge and experience necessary to succeed in this complex legal field. For additional information about this or other news stories, contact ZK toll-free at (888)841-9623. Initial consultations are always free and confidential.
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
